Lenvatinib Mesylate CAS 857890-39-2

Khoom Qhia:

Khoom npe: Lenvatinib mesylate CAS TSIS: 857890-39-2

Txhais:

4- [3-chloro-4- (N' -cyclopropylureido) phenoxy] -7-methoxyquinoline-6-carboxamide mesylate;

Tshuaj& Cov Khoom Uas Lub Cev:

Zog: cov hmoov dawb dawb

Ntsuas: ≥99.0%

Lovatinib mesylate yog lub mesylate ntawm levatinib. Lovatinib yog ntau lub hom phiaj tyrosine kinase inhibitor tsim los ntawm Eisai Nyij Pooj. Nws muaj hom tshiab khi hom. Ntxiv rau kev tiv thaiv lwm cov pro-angiogenic thiab oncogenic signaling pathways ntsig txog tyrosine kinases koom nrog qog loj hlob, nws tuaj yeem xaiv qhov kev tiv thaiv kinase kev ua haujlwm ntawm vascular endothelial kev loj hlob (VEGF) receptors, xws li VEGF-1, VEGF-2 thiab VEGF- 3 thiab lwm yam.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: lenvatinib mesylate cas 857890-39-2, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: Triethyl Orthobenzoate CAS 1663-61-2
• Tom ntej: 5,6-Dihydro-3- (4-morpholinyl) -1- (4-nitrophenyl) -2 (1H) -pyridinone CAS 503615-03-0